TY  - JOUR
AU  - Patrick Choueiry
AU  - Pierre Haddad
AU  - Joe Baroudy
AU  - Rana Fassih
AU  - Salma Tradieh
AU  - Joseph Kareh
AU  - Wassim Jreij
AU  - Tanios Otayek
AU  - Imad Elias
AU  - Paul Makhlouf
AU  - Mariam Farhat
AU  - Jihad Ezzedine
AU  - Mohamad Hayek
AU  - Lina Jarrah
AU  - Rola Deeb
AU  - Iman Akoush
PY  - 2025
DA  - 2025/03/28
TI  - Safety and Efficacy of Feroxyl®, a Special Iron Bisglycinate Preparation in Improving Hemoglobin and Blood Biomarkers in Lebanese Patients with Iron Deficiency and Iron Deficiency Anemia: A Retrospective Chart Review
JO  - Archives of Clinical Trials
VL  - 5
IS  - 1
AB  - Anemia is a widespread public health issue, with iron deficiency anemia (IDA) responsible for 50% of
cases. This study evaluates the effectiveness of Feroxyl, a ferrous bisglycinate supplement enriched with
vitamins, in improving hemoglobin and other blood biomarkers among a cohort of Lebanese patients
with ID or IDA. A retrospective chart review of 593 patients showed significant improvements in
hemoglobin (1.81 g/dL increase) and biomarkers like MCV, MCH, as well as ferritin after three months
of supplementation. Vitamin D also significantly Increased. The supplement was well-tolerated, with
mild side effects, making Feroxyl a promising treatment for IDA, particularly in low-resource settings.
SN  - 2768-4598
UR  - https://dx.doi.org/10.33425/2768-4598.1050
DO  - 10.33425/2768-4598.1050